AGO2 and cholangiocarcinoma: RIP assay showed the abundant enrichment of HCG18 and miR-424-5p in the precipitates of anti-Ago2, which indicated that HCG18 bound with miR-424-5p in cholangiocarcinoma cells (Fig. 6B).